The Risk of Cardiovascular Disease Risk Among Adults with Vision Impairment from Low-, Middle- and High-Income Countries.

IF 1.7 4区医学 Q3 OPHTHALMOLOGY

Ophthalmic epidemiology Pub Date : 2024-06-04 DOI:10.1080/09286586.2024.2354695

Duke Appiah, Hannah Chaudhury, Tristin Chaudhury, Marvelyn Iweh, Obadeh Shabaneh, Noah De La Cruz

{"title":"The Risk of Cardiovascular Disease Risk Among Adults with Vision Impairment from Low-, Middle- and High-Income Countries.","authors":"Duke Appiah, Hannah Chaudhury, Tristin Chaudhury, Marvelyn Iweh, Obadeh Shabaneh, Noah De La Cruz","doi":"10.1080/09286586.2024.2354695","DOIUrl":null,"url":null,"abstract":"Purpose: The limited evidence for cardiovascular disease (CVD) among adults with vision impairment (VI) has often been from developed countries using self-reported VI. This study evaluated the association of objectively-determined VI with the risk of CVD among adults from low-, middle-, and high-income countries.Methods: Data were from 32,268 adults aged 30-74 years without CVD or blindness from China, Ghana, India, Mexico, Russian Federation, South Africa, and the United States during 2007-2010. VI and severe VI was defined as presenting visual acuity worse than 6/18, and 6/60, respectively. The Framingham risk algorithm was used to estimate the risk for incident CVD. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals.Results: The mean age of participants was 46.4 years, with half of them being women (49.3%). The age-adjusted prevalence of VI ranged from 1.1% (United States) to 14.2% (South Africa) while severe VI ranged from 0.4% (United States) to 4.5% (Ghana). In models adjusting for country, sociodemographic factors, waist girth, healthcare use, activities of daily living and other health-related factors, VI was associated with CVD risk ≥ 10% (OR = 1.69, 95% CI: 1.22-2.36). This observed association was largely consistent across countries (p = 0.119). The observed CVD risk was similar among adults with moderate or severe VI (OR = 0.95, 95% CI: 0.50-1.83). CVD risk was higher among adults with VI who were <65 years old (OR = 1.89, 95% CI: 1.36-2.63) or were employed (OR = 2.24, 95% CI: 1.58-3.16).Conlusions: This cross-national study shows that individuals with VI are at high risk for future CVD.","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-8"},"PeriodicalIF":1.7000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2024.2354695","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The limited evidence for cardiovascular disease (CVD) among adults with vision impairment (VI) has often been from developed countries using self-reported VI. This study evaluated the association of objectively-determined VI with the risk of CVD among adults from low-, middle-, and high-income countries.

Methods: Data were from 32,268 adults aged 30-74 years without CVD or blindness from China, Ghana, India, Mexico, Russian Federation, South Africa, and the United States during 2007-2010. VI and severe VI was defined as presenting visual acuity worse than 6/18, and 6/60, respectively. The Framingham risk algorithm was used to estimate the risk for incident CVD. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals.

Results: The mean age of participants was 46.4 years, with half of them being women (49.3%). The age-adjusted prevalence of VI ranged from 1.1% (United States) to 14.2% (South Africa) while severe VI ranged from 0.4% (United States) to 4.5% (Ghana). In models adjusting for country, sociodemographic factors, waist girth, healthcare use, activities of daily living and other health-related factors, VI was associated with CVD risk ≥ 10% (OR = 1.69, 95% CI: 1.22-2.36). This observed association was largely consistent across countries (p = 0.119). The observed CVD risk was similar among adults with moderate or severe VI (OR = 0.95, 95% CI: 0.50-1.83). CVD risk was higher among adults with VI who were <65 years old (OR = 1.89, 95% CI: 1.36-2.63) or were employed (OR = 2.24, 95% CI: 1.58-3.16).

Conlusions: This cross-national study shows that individuals with VI are at high risk for future CVD.

查看原文本刊更多论文

来自低收入、中等收入和高收入国家的视力受损成年人患心血管疾病的风险。

目的：视力障碍（VI）成人心血管疾病（CVD）的有限证据通常来自发达国家，使用的是自我报告的视力。本研究评估了低收入、中等收入和高收入国家成年人中客观测定的视力障碍与心血管疾病风险之间的关系：数据来自 2007-2010 年间中国、加纳、印度、墨西哥、俄罗斯联邦、南非和美国的 32,268 名年龄在 30-74 岁之间、无心血管疾病或失明的成年人。六度弱视和严重六度弱视的定义分别为视力低于6/18和6/60。弗雷明汉风险算法用于估算心血管疾病的发病风险。逻辑回归用于计算几率比（OR）和 95% 的置信区间：参与者的平均年龄为 46.4 岁，其中一半为女性（49.3%）。经年龄调整后，VI 患病率从 1.1%（美国）到 14.2%（南非）不等，而严重 VI 患病率从 0.4%（美国）到 4.5%（加纳）不等。在对国家、社会人口因素、腰围、医疗保健使用情况、日常生活活动和其他健康相关因素进行调整的模型中，VI 与心血管疾病风险≥ 10%相关（OR = 1.69，95% CI：1.22-2.36）。在不同国家观察到的这种相关性基本一致（P = 0.119）。观察到的心血管疾病风险在中度或重度 VI 的成人中相似（OR = 0.95，95% CI：0.50-1.83）。患有心血管疾病的成年人中，凝血功能障碍患者的心血管疾病风险更高：这项跨国研究表明，VI 患者未来患心血管疾病的风险很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmic epidemiology 医学-眼科学

CiteScore

3.70

自引率

5.60%

发文量

审稿时长

6-12 weeks

期刊介绍： Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.